CA2362981C - A method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body - Google Patents
A method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body Download PDFInfo
- Publication number
- CA2362981C CA2362981C CA002362981A CA2362981A CA2362981C CA 2362981 C CA2362981 C CA 2362981C CA 002362981 A CA002362981 A CA 002362981A CA 2362981 A CA2362981 A CA 2362981A CA 2362981 C CA2362981 C CA 2362981C
- Authority
- CA
- Canada
- Prior art keywords
- image
- patient
- instrument
- structural
- imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title abstract description 31
- 238000003384 imaging method Methods 0.000 claims description 42
- 206010028980 Neoplasm Diseases 0.000 claims description 25
- 210000000056 organ Anatomy 0.000 claims description 14
- 201000011510 cancer Diseases 0.000 claims description 7
- 238000002603 single-photon emission computed tomography Methods 0.000 claims description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 6
- 210000004556 brain Anatomy 0.000 claims description 6
- 210000003734 kidney Anatomy 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- 210000000481 breast Anatomy 0.000 claims description 4
- 238000012633 nuclear imaging Methods 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 210000000496 pancreas Anatomy 0.000 claims description 3
- 239000012857 radioactive material Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 238000012879 PET imaging Methods 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims 2
- 210000001072 colon Anatomy 0.000 claims 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 210000001165 lymph node Anatomy 0.000 claims 2
- 230000036210 malignancy Effects 0.000 claims 2
- 210000001672 ovary Anatomy 0.000 claims 2
- 210000002307 prostate Anatomy 0.000 claims 2
- 210000000664 rectum Anatomy 0.000 claims 2
- 210000001685 thyroid gland Anatomy 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 230000001766 physiological effect Effects 0.000 claims 1
- 238000002591 computed tomography Methods 0.000 description 22
- 238000001574 biopsy Methods 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 8
- 238000002595 magnetic resonance imaging Methods 0.000 description 7
- 238000002725 brachytherapy Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 230000004807 localization Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 238000009206 nuclear medicine Methods 0.000 description 4
- 239000012217 radiopharmaceutical Substances 0.000 description 4
- 229940121896 radiopharmaceutical Drugs 0.000 description 4
- 230000002799 radiopharmaceutical effect Effects 0.000 description 4
- 206010025323 Lymphomas Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 238000002600 positron emission tomography Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000013170 computed tomography imaging Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000033912 thigmotaxis Effects 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- AOYNUTHNTBLRMT-SLPGGIOYSA-N 2-deoxy-2-fluoro-aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O AOYNUTHNTBLRMT-SLPGGIOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 238000002672 stereotactic surgery Methods 0.000 description 1
- ACTRVOBWPAIOHC-XIXRPRMCSA-N succimer Chemical compound OC(=O)[C@@H](S)[C@@H](S)C(O)=O ACTRVOBWPAIOHC-XIXRPRMCSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/12—Arrangements for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
- A61B6/5235—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image combining images from the same or different ionising radiation imaging techniques, e.g. PET and CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/52—Devices using data or image processing specially adapted for radiation diagnosis
- A61B6/5211—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
- A61B6/5229—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image
- A61B6/5247—Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data combining image data of a patient, e.g. combining a functional image with an anatomical image combining images from an ionising-radiation diagnostic technique and a non-ionising radiation diagnostic technique, e.g. X-ray and ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/10—Computer-aided planning, simulation or modelling of surgical operations
- A61B2034/107—Visualisation of planned trajectories or target regions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B34/00—Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
- A61B34/20—Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B2034/2072—Reference field transducer attached to an instrument or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/10—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis
- A61B90/11—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges for stereotaxic surgery, e.g. frame-based stereotaxis with guides for needles or instruments, e.g. arcuate slides or ball joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Robotics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pulmonology (AREA)
- Theoretical Computer Science (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Method and system are presented for guiding a diagnostic or therapeutic instrument (20) towards a correct target (TG) inside the patient's body. A combined image obtained by registering structural and functional images of at least a portion of the patient's body (10) including the target (TG) is used together with a guiding device (18).
The guiding device (18) has an indicator associated with the instrument (20), and is operable for presenting data indicative of a position of a location on the instrument (20) relative to any other point in the at least portion of the patient's body (10). The guiding device (18) is connectable to a computer device (24), displaying the combined image and operable thereby for guiding the instrument (20) towards the target (TG).
The guiding device (18) has an indicator associated with the instrument (20), and is operable for presenting data indicative of a position of a location on the instrument (20) relative to any other point in the at least portion of the patient's body (10). The guiding device (18) is connectable to a computer device (24), displaying the combined image and operable thereby for guiding the instrument (20) towards the target (TG).
Description
WO 00/49958 PCTnIA0100113 A Method and System for Guiding a Diagnostic or Therapeutic Instrument Towards a Target Region Inside the Patient's Body FIELD OF THE IPdVENTION
The present invention is generally in the field of the diagnosis and treatment of ailments such as cancer, and relates to a method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body.
BACKGROUND OF THE INVENTION
Diagnostic and therapeutic techniques aimed at diagnosing and treating cancerous tumors are known and widely used. Some of them involve the insertion of an instrument such as a needle, fiotn outside the patient into a tumor that is Io suspected of being cancerous. For example, a biopsy needle commonly is inserted into a tumor to withdraw a tissue sarnple for biopsy. In brachytherapy, a radioisotope is placed at the tip of a needle, and the tip of the needle is inserted into the tumor to deliver radiation to the tumor with minimal irradiation of the surrounding healthy tissue. Although not common in medical practice, chemotherapeutic agents also may be injected into the tumor using a needle.
Such needles are often inserted into the patient utilizing a series of struchual images of the patient, such as ultrasound images, images obtained with Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) tecbniques. These images are acquired before and during the insertion of the instrument, to verify that the instnunent is being directed towards the correct target and is bypassing organs such as blood vessels, which should not be penetrated by the instnunent.
,. - 2 Since a tumor may include"both cancerous tissue and non-cancerous tissue, it is important to be able to direct an instrument specificaIly to a cancerous portion of a tdnor, and to avoid misdiagnosis from the non-cancerous portion of a tumor.
In the case of a biopsy, the needle should be directed towards the portion of the tumor that is most likely to be cancerous. In the case of brachytherapy, the needle should be directed towards the cancerous portion of the tumor. Structural imaging modalities, such as CT and MRI, that have enough spatial accuracy and resolution to distinguish and resolve tumors, are nevertheless unable to differentiate cancerous tissue from non-cancerous tissue. Functional imaging modalities, including lo tomographic nuclear imaging modalities, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET),. can distinguish cancerous tissue from non-cancerous tissue, but lack the spatial ~:.
{ accuracy and resolution that is needed for the accurate positioning of instruments such as biopsy needles and brachytherapy needles.
Techniques for registering a functional image with a structural image to produce a combined image have been developed, and are disclosed, for example in the following publications: M. W. Vannier and D. E. Gayou, "Automated registration of multimodality images", Radiology, vol. 169 pp. 860-86I (1988);
J.
A. Correia, "Registration of nuclear medicine images, J. Nucl. Med, vol. 31 pp.
1227-1229 (1990); J-C Liehn, A. Loboguerrero, C. Perault and L. Demange, "superposition of computed tomogra.phy. . and single photon emission tomography l.. immunoscinigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrenee", Eur. J. Nucl. hled., vol. 19 pp. 186-194 (1992); F.
Thomas et al., "Description of a prototype emission transmission computed.
tomography imaging system",.J.' Nucir Med., vol. 33 pp: 1881-1887 (1992); D.
A.
Weber and M. Ivanovic, "Correlative image registration", Sem. Nuel. Med, vol, pp. 311-323 (1994); and Hasegawa et al., US Patent No. 5,376,795: In principle, a sequence of such combined images could be used to direct an instrument to the cancerous portion of a tumor. In practice, the multiple WO 00149958 PCr/iIA0100113 imaging sessions and registrations that this would require make this solution impractical and possibly dangerous.
Stereotaxis is a known technique for localizing a region inside the body of a patient from outside the body of the patient, and for directing an instrument such as a needle, or a narrow beam of therapeutic radiation, to the target region. The degree of accuracy obtained from stereotaxis is relatively high, so this technique has been considered useful mainly on the brain and the breast. In stereotactic surgery of the brain, a CT localization frame is attached rigidly to the head of a patient and a CT
image of the patient's brain is acquired with the CT localization frame in place. The io position of the CT localization frame in the CT image is used to position the patient with respect to a surgical instrament utilizing a source of radiation so that the beam or beams of radiation intersects the desired target. Note that the CT
localization firame is removed from the patient's head before the therapeutic irradiation commences.
Additionally, in order to access a correct location inside a patient's body with a diagnostic or therapeutic instruinent, it is desirable to have exact information on the physical dimensions of the instrument. Using existing tools, such informafion can be obtained by one of the following means: prompting the user to enter all relevant physical dimensions; keeping a software library of known instruments and prompting the user for a specific model type; or prompting the user to perform a series of actions with a caL'bration device. Needless to say, these are cumbersome and time-consuming procedures, and require caregiver assistance.
SUMMARY OF THE INYENTION
There is accordingly a need in the art to facilitate the technique of accessing a correct target region inside the patient's body with a diagnostic or therapeutic instivment, aimed at diagnosis and therapy purposes, by providing a novel method and system for guiding the instrument towards the target region, which is not necessarily located in the head or breast.
It is a major feature of the present invention to provide such a method that utilizes a combined image of at least a portion of the patient's body including a target region, which image is obtained by registering a high-resolution structural image and a relatively low-resolution functional image of this portion of the s patient's body.
It is a further feature of the present invention to provide such a system that utilizes a guiding device having an indicator associated with a diagnostic or therapeutic instrument for presenting data indicative of a position of the indicator relative to any other point in the chosen portion of the patient's body.
The main idea of the present invention consists of the utilization of a combined image, obtained by registering structural and functional images of at least a portion of the patient's body including a target region, for guiding an instrument (diagnostic or therapeutic) towards the target. The structural and fimctional images are obtained using, respectively, structural and functional modalities, namely -Is suitable known techniques, and the combined image is obtained by using any known suitable technique, for example, those disclosed in the above publications.
As used herein, the term "target" refers to a structarally discrete portion in the patient's body, such as an organ or a tuinor, that is suspected of containing diseas (e.g., cancerous tissue). This diseased tissue (target) is surrounded by healthy tissues (e.g., non-cancerous tissue).
As used herein, the term "instrument" refers to a diagnostic or treatment instrument that can access and, if desired, be inserted into the target from outside the patient for the purpose of either diagnosis or treatment of a disease.
Typical examples of such instiniments include biopsy needles and needles for brachytherapy 2s and chemotherapy.
According to one broad aspect of the present invention, there is provided a method for guiding an instrument towards a correct target inside the patient's body, the method comprising the steps of:
(i) providing an image of at least a portion of the patient's body including said target, wherein said image presents a combined image = WO 00/49958 PC1'/ll.UU1o0113 of registered structural and functional images of said at least portion of the patient's body;
(ii) providing. data indicative of a position of a location on the instruinent relative to any other point in said at least portion of the patient's body;and (iii) directing the instrument to said target.
To provide the combined image, the structtn-id and fnnctional images are obtained with, respectively, structural and fimctional modalities and registered.
While directing the instrument towards the target, at least one additional image of io the at least portion of the patient's body is preferably acquired with at least one of structural or functional modalities, for obtaining at least one additional combined image. Several additional images may be periodically or continuously acquired, and consequently, several additional combined images be obtained.
The structural and functional images used for obtaining the combined image may be, respectively, high-resolution and relatively low resolution. The resolution of 3-5mm pixel size is considered to be low, and that of less than Inun pixel size is considered to be high resolution. In this case, the at least one additional image may be a low-resolution functional image . or relatively higher resolution struchxral images (the so-called "medium-resolution" structural image). Alternatively, the structural and functionai images used for obtaining the combined image may each be of a low resolution, in which case the at least one additional image is acquired with high-resolution structural modality.
To provide the data indicative of the relative position of the instcument, a guiding device is used having an indicator associated with the instrament.
The guiding device may comprise a fi.-ame attachable to the patient's body and a stereotactic guide. The indicator is in the form of at least three markers on the frame. In this case, to provide the combined 'unage, the following steps are performed. The frame is rigidly secured to the patient, and then the high-resolution structural image is acquired using a high-resolution structural imaging modality, 3o such as CT or MRI. This high-resolution struchmal image includes at least the portion of the patient's body. The markers are used- by taking a series of structural images that covers all of them, since they are located in different planes. To acquire the functional image to.be registered with the so-obtained high-resolution structural image, a suitable radiopharmaceutical, that is taken up preferentralIy by cancerous S tissue (i.e., target), is injected into the patient, and the portion of the patient's body that was imaged with the stnictural modality is again imaged using a lower-resolution functional imaging modality that records radiation emitted by the radiopharmaceutical to acquire an image of the target. The structural image and the functional image are then registered to provide the combined image that shows the io relative location of the target relative to other elements in the combined image. In other words, the combined image shows which part of a twnor mass seen in the structural image contains cancer, and where the cancerous areas are located on the high-resolution structural image.
Prior to performing step (iii), the stereotactic guide is rigidly attached to the-1s fiame. Since the position of the target (e.g., cancerous tissue) relative to the frame is known, the position of the target relative to the stereotactic guide is also known.
The stereotactic guide then is used, under computer control, to guide the instrument, such as a biopsy needle or a brachytherapy needle, to the target, with reference to the pixels of the combined image that represent the markers and the 20 target. The trajectory of the instrument is programmed in advance so that the instiument does not penetrate organs, such as vascular structures, that should not be penetrated.
According to another broad aspect of the invention, there is provided a method for accessing a target in a patient's body with an instrument, the method 2s comprising the steps of:
(a) providing a guiding device having a frame to be secured to the patient and a stereotactic guide assembly, wherein the frame carries an indicator in the form of at least three markers;
(b) rigidly securing said frame to the patient;
WO DU/49958 PCTlIIAQ/00113 (c) imaging at least a portion of the patient's body including the target, using a structural imaging modality, to produce a siructural image of the at least portion of the patient's body and at least one of the markers, and acquiring a series of images to image all the markers and estimate their location in said structural image;
(d) imaging the at least portion of the patient's body using a functional imaging modality to produce a functional image of the at least portion of the patient's body; and (e) registering the functional image with the structural image to produce a combined image, (f) rigidly attaching said stereotactic guide assembly to said frame, and (g) directing the instrument to the target, using the stereotactic guide, with reference to said markers as imaged in the combined image.
According to another embodiment of the invention, the guiding device is a so-called tracking system composed of a guiding reference unit providing data indicative of space coordinates of the indicator that is in the form of a sensor attachable to the instrument at its handle portion, and a guiding controller.
The latter is interconnected between the indicator and the guiding reference, and is connected to a computer device displaying the combined image. Such a tracking system may be of any known type, e.g., magnetic, optical, inertial, sound-waves, GPS. The construction and operation of the tracking system are known per se, and do not form part of the present invention. Therefore, the operation of the tracking system does not need to be specifically described, except to note the following. The controller is capable of tracking the position of a sensor and obtaining the information indicative of six degrees of freedom (i.e., 3 position coordinates and 3 rotation angles). The controller is installed with suitable hardware and is operated by suitable software for performing a signal processing technique and generating data indicative of the sensor's position in the coordinate space defmed by the guiding reference. The computer device analyzes this data to generate a graphic WO 00/49958 PCT/1I.00/00113 -$-representation of instrument location on the structural or functional image, or directiom instructions for guiding the instrument towards'the target.
Magnetic tracking systems are based on a magnetic/electronic field, transmitter (guiding reference) and a relatively small receiver (indicator).
Such a system may, for example, be the miniBIItD 'model, commercially available from Ascension Technology Corporation. Optical tracking systems apply a visual perception technique that observes either light reflected items or small light emitters, for example POLARIS models, commercially available from Northern Digital Inc.
Additionally, the indicator may comprise an identification electronic chip attached to the handle-portion of the instrument. This is actually a chip with an mb dded application, such as a miniature electironic rnemory chip Prograrmued during the manufacture of the specifie instrument. The chip may be 'equipped with a transmitting utility generating and transmitting data indicative of the physical is dimensions of the instrument or its corresponding code in accordance with a coded library. Alternaxively or additionally, the chip may comprise a magnetic strip or a bar code to be read by a suitable reading head associated with the computer device.
According to another broad aspect of the present invention, there is provided a system for guiding an instrument towards a correct target inside the patient's 2o body, the system comprising:
1 - a computer device for displaying an image of at least a portion of the patient's body including said target, wherein said displayed image presents a combined image of registered structural and functional images _ of said at least portion of the patient's body;
25 - a guiding device having an indicator associated with said instrument for presenting data indicative of a position of a location on the instrument relative to any other point in said at least portion of the patient's body, said guiding device being connectable to said computer device and operable thereby for directing the instrument to said target.
*Trade-mark WO 00149958 PCT/IL00l00113 Freferably, the system also comprises an additional imaging modality capable of acquiring at least one of structuml and functional images of said at least portion of the patient's body. This additional imaging modality is operable for acquiring at_ least one image, used for obtaining at least one additional combined image (a so-called "updated combined image"). This at least one additional combined image is utilized, while directing the instrument towards the target.
Although the scope of the present invention includes the diagnosis and treatment of any diseased tissue, the present invention is described below in terms of the primary application thereof, the diagnosis and treatment of cancer.
to BRIEF DESCRIPTION OF THE DRAWIlNGS
In order to understand the invention and to see how it may be carried out in practice, a preferred embodiment will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
Fig. 1 shows a patient wearing a frame;
Figs. 2A to 2C schematically illustrate axial sections of a Ga-67, a CT and a combined image of a chest of a patient;
Fig. 3 shows the patient of FIG. I with a stereotactic guide attached to the frame;
Fig. 4 illustrates the main constructional parts of a system according to 2o another embodiment of the invention;
Fig. 5 i1lUstrates another feature of the present invention suitable to be used in the embodiment of Figs. 1 and 3, or the embodiment of Fig. 4;
Figs. 6a and 6b illustxate two more examples of an indicator suitable to be used in the present invention; and Fig. 7 illustrates some more features of a method and system according the invention.
WO 00/49958 PCT/II.00/00113 DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
Referring to Figs. 1-3, there is illustrated one embodiment of the present invention utilizing a niethod of stereotactic diagnosis and treatment of diseased tissue. Fig. 1 shows a patient 10 wearing a rigid frame 12. By virtue of being snugly S fitted to the shoulders, waist and groin of patient 10, frame 12 is rigidly secured to patient 10. Frame 12 bears thereon three markers 14 (constituting an indicator) that include a material that shows up well in a high-resolution structural image of the patient 10 and fiame 12. For example, if CT is used for structural imaging, markers 14 are lead blocks. If MRI is used for structural imaging, markers 14 are hollow to plastic blocks filled with a solution of Gd-DTPA. Frame 12 also bears three attachment points 16 for a stereotactic guide. A high-resolution stntctural image of the portion of patient 10 that contains the target is acquired while patient 10 wears frame 12 as shown in Fig. 1.
Three is the. minimum number of markers 14 that is needed for accurately 15 recording the relative positions of frame 12 and the internal tissues of patient 10 in three dimensions in the structural image. Markers 14 are shown in Fig. 1 as three blocks only for illustrational clarity. Any suitable marker geometry or form may be used, for example, vertical and diagonal rods, as are used in the BRW ' CT
localization frame conunercially available from Radionics. Inc., of Burliuigton MA
20 and from Sofamor Danek, of Elektra, Sweden, for stereotactic 'treatment of the ( .t.. patient's brain. The positioning of markers 14 and attachment points 16 on frame 12 in Fig. 1 also is only illustrative, as an example of appropriate positions of markers 14 and attachment points 16 for treatment of the abdomen of patient 10.
Subsequent to or simultaneously with the acquisition of a high-resolution 25 structural (e.g., CT or MRI) image of the portion of patient 10 that includes the target (while the patient wears the frame), a lower resolution functional (e.g., nuclear medicine) image of the same portion of patient 10 is acquired for the purpose of imaging the target in the entire portion imaged by the structural modality. If the disease under treatment is cancer, then the preferred imaging *Trade-mark modality is nuclear imaging, and the patient is injected before imaging with a radiopharmaceutical that is preferentially taken up by cancerous tissue.
Examples of such radiopharmaceuticals include Ga-67, Tc-99m MEBI, T1-201, F-18 fluorodeoxyglucose and In-i l l octreotide. The most preferred nuclear imaging modalities are tomographic modalities such as SPECT and PET. The functional and structural images then are registered, for example as described. in the paper by Weber and Ivanovic cited above, to produce a combined image.
Fig. 2A is a schematic illustration of an axial section of a Ga-67 image If...
of a chest of a cancer patient, showing a tumor T containing a lymphoma that to constitutes the target TG to be accessed by an instrument (not shown). Fig.
2B is a schematic illustration of an axial section of a CT image Iu,n of the same patient's chest. A portion P of the patient's body including the tumor T is imaged. The target TG is not seen in the structural image since there is typically no visual contrast in such image between the lymphoma and the rest of the tumor. What can Is be seen in such a structural image are organs and tissues, generally at OR, surrounding the tumor T (and consequently the target to be detected), and typically one of the markers 14 on the frame. Although three markers are presented in the drawings as seen in the structural image, two of them are shown in dotted lines, since the markers are located in different planes, and only one of them will be seen 2o in such a sectional view. Fig. 2C is an axial section of a combined image Ic,m, showing the functional image It~.. of Fig. 2A registered on the structural image I,a of Fig. 2B. Any known suitable technique can be used for registering images of Figs. 2A and 2B to obtain the combined image of Fig. 2C, for example the techniques descnbed in the above-indicated publications. Biopsy and therapy 25 directed towards the tumor should be aimed specifically at the lymphoma.
Fig. 3 shows patient 10 with a stereotactic guide 18 finnly and rigidly attached to frame 12 at attachment points 16, and with a diagnostic or therapeutic insttvment 20, such as a biopsy needle or a brachytherapy needle, mounted in stereotactic guide 18 in its ready-for-insertion position to be inserted into the 3o abdomeii of patient 10 under the control of a computer device 24.
WO 00/49958 PCT/IUl0/00113 Computer 24 is equipped with suitable hardware and operated by suitable software for sending control signals, including the relevant Cartesian coordinates, to stereotactic guide 18 via suitable signal communication means, for example electrical connection such as a cable 22. It should be understood, although not specifically shown, that wireless connection could be used. Computer 24 also includes a suitable display mechanism, such as a video terminal, for displaying the combined image.
A physician programs the trajectory of instrument 22 in computer 24 in advance, with reference to the position of the target TG and the other intemal organs OR ofpatient 10, and with reference to markers 14, as seen in the combined image I.. Computer 24 is installed with suitable software that transfonns data indicative of the coordinate system of the combined image, as defined by markers 14, into the coordinate system of stereotactic guide 18. This software is used to transfonn the coordinates of the trajectory, which is defined by the physician in the coordinate system of the combined image, into the coordinate system of stereotactic guide 18, to enable stereotactic guide 18 to steer instrument 20 along the desired tqajeetoid. The physician designs the trajectory to avoid vascular structures and other organs that should not be penetrated by instrament 20.
To assist the physician in recognizing and avoiding vascular structures such -~
2o as blood vessels, another functional image of the portion of patient 10 that includes the target is acquired, for the purpose of imaging the blood vessels. The preferred imaging modality for imaging vascular structures is Tc-99m labeled red blood cells SPECT. For this purpose, patient 10 is frst injected with Tc-99m, to label the red blood cells of patient 10. The SPECT image of the vascular structures is registered with the structural image initially obtained and utilized in the initial combined image shown in Fig. 2C, and a resulting second combined image is displayed by computer 24 and is used by the physician in planning the trajectory of instrument 20 to avoid penetration of the imaged vascular structures.
Similarly, to assist the physician in recognizing and avoiding organs such as the kidneys, another functional image of the portion of patient 10 that includes the II
target is acquired. In the specific case of the kidneys, this second fanctionai image is a SPECT image obtained using Tc-99 DMSA. The SPECT image of the organ or organs is registered with the structural image, and the resulting second combined image is displayed by computer 24 and is used by the physician in planning the trajectory of instnunent 20 to avoid penetration of the imaged organs. To prevent errors in planning the trajectory of instrument 20, computer 24 is programmed to avoid penetration of blood vessels and organs with a high blood pool, and other organs that should not be penetrated, such as the gut, the kidneys, the pancreas and the heart.
10It should be understood that more than one additional combined image can be obtained, the number of these additional images depending on a specific application, e.g., a target to be accessed. A physician himself decides how many updates of the initial combined 'unages are needed for successfully guide the instrument towards the target.
In the above-described example of the present invention, the biopsy needle guidance utilizes the stereotactic guide assembly, with reference to the diseased portion of the patient's body and to the markers as imaged on the first combined image. In other words, in the above-described example, a guiding device is constituted by the frame with markers and by the stereotactic guide assembly.
2o However, other guidance and motion tracking systems are suitable as well.
Such systems are, but not lirnited to magnetic and optical systems.
Reference is made to Fig. 4, ilhistrating the main components of a system, generally designated 100, according to another emboditnent of the invention.
System 100 is composed of an indicator 126 appropriately attached to a handle 2s portion 122 of an instnunent 120, a guiding reference unit 128 and a guiding controller 130 connected to the computer 24.
As indicated above, such a system may be of magnetic or optical kind,for example, commercially, available from Ascension Technology Corporation and Northern Digital Inc., respectively. Generally speaking, the guiding reference unit 30 128 and the indicator 126 operate together to generate data indicative of the indicator position in a 6D coordinate space (3 position coordinates and 3 rotation angles) and transmit this data to the guiding controller 130. The latter h ansmits corresponding data to the computer device 24, which registers this data with the combined image to generate a graphic representation of the instrument's location s. on the structural or functional image or direction instructions for guiding the instrument 120 towards the target, as described above.
Turning now to Fig. 5, there. is illustrated an inshwnent 220 having a handle portian 222 formed with an identification chip 226. As indicated above, a major factor in the accuracy of the system of the kind specified is exact information on lo the physical dimensions of a diagnostic or therapeutic instrument associated with a guiding device. To this end, the diagnostic or therapeutic instrument 220 according to the invention is equipped with the chip 226 with an embedded application enabling the identification of the physical dimensions of the specific instmment.
The chip provides data indicative of the inshvment's physical parameters, which 15 may be d'umensions themselves, or coded data that can be identified by the software installed in the computer 24 (i.e., library storing information corresponding to various Serial Numbers of diagnostic 'and therapeutic instnunents manufactured by various manufacturers). The computer 24 itself may have a special utility for communicating with the embedded application of the chip.
20 According to the present invention, diagnosis and/or treatment are performed with respect to an image of the target region in the patient's body that combines a high-resolution structural image, such as a CT or MItI image, with a lower resolution fimctional image, such as a nuclear image. The combined image may be used to assist the caregiver in locating the instrument with respect to the 25 target. Pieces of materials that are clearly shown in one of the modalities may be used to gain information in the combined image. Such materials are, but not limited to, radioactive emitters that are clearly seen by means of the nuclear medicine image, and lead capsules that are highly visible in a CT image. Such pieces can be attached to known locations on the therapeutic instnunent, thereby serving as 30 indicators. These indicators are useful in the procedure navigation process, where WO UU/49958 PCTn1.00/00113 the physician inserts the instrtunent toward the target. At the end of the procedure there is a verification phase, where the physician validates the location of the instrurnent with respect to the target. During the verification phase both the tissue and the highlight indicator are clearly seen in the combined image. This increases S the degree of confidence that the prqcedure instmmnent was correctly applied.
Fig. 6A shows the main principles of the above concept. Here, such an indicator 326 (e.g., radioactive emitters) is attached to a location on an instrvment 320 close to its handle portion 322.
Fig. 6B illustrates an example where treatment of the target is needed. To io this end, a therapeutic instrument 420 is at its distal end formed with a suitable materiat 422 that can be clearly seen in an image of one of the modalities to gain information in the combined image. Thus, the therapeutic instrument 420 is initially inserted by its distal end into a vessel containing materia1422, and is then directed towards the target TG. Such materials are, but not Iimited to, radioactive materials ts that are clearly seen by means of the nuclear medicine image, and iodine that is highly visi'ble in a CT image. The highlight material may also be mixed with the therapeutic chemical in advance. The highlight materials are injected together with therapeutic chemical substances and are used to track the absorption of the substances with respect to the tumor while minimizing damage to the seurounding 2o healthy tissue.
As indicated above, diagnosis is performed with respect to an image of the target region of the patient that combines a high-resolution structural image, such as a CT or MRI image, with a lower resolution functional image, such as a nuclear image. For various reasons, a physician may prefer to perform the clinical 25 procedure under single modality equipment that may be different from the equipment originally used to make the combined image. In this case, the combined image is made of a relatively high-resolution structural image, lower resolution functionai imaga, and another image that may be eitheD stwctin-al on functional of a different resolution. For example, a low-resolution PET image may be combined 30 with a medium-resolution CT image, which images are collected during a preliminarydiagnostic procedure. The actual procedure is carried out under a high-resolution CT or MRI imaging, that was designed for such procedures.
The above concept is schematically iIlustrated -in Fig. 7, showing a system 50 utilizing low-resohrtion CT imaging modality (as compared to that used during the instnnnent insertion procedure) and low-resohrtion PET imaging modaiity, generally at 502, that obtain a combined image of a portion of the patient's body including a target and transniit- data to a computer device 24 and to a high-resolution CT modality 504 through a computer network. A guiding device 506 associated with a diagnostic or therapeutic instrwnent 520 and coupled to the i o computer 24, is used for guiding the instiument towards the target with simultaneous image acquisition with the high-resolution CT imaging modality 504:
Those skilled in the art will readily appreciate that various modifications and changes can be applied to the preferred embodiment of the invention as hereinbefore described without departing from its scope defined in and by the appended claims.
The present invention is generally in the field of the diagnosis and treatment of ailments such as cancer, and relates to a method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body.
BACKGROUND OF THE INVENTION
Diagnostic and therapeutic techniques aimed at diagnosing and treating cancerous tumors are known and widely used. Some of them involve the insertion of an instrument such as a needle, fiotn outside the patient into a tumor that is Io suspected of being cancerous. For example, a biopsy needle commonly is inserted into a tumor to withdraw a tissue sarnple for biopsy. In brachytherapy, a radioisotope is placed at the tip of a needle, and the tip of the needle is inserted into the tumor to deliver radiation to the tumor with minimal irradiation of the surrounding healthy tissue. Although not common in medical practice, chemotherapeutic agents also may be injected into the tumor using a needle.
Such needles are often inserted into the patient utilizing a series of struchual images of the patient, such as ultrasound images, images obtained with Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) tecbniques. These images are acquired before and during the insertion of the instrument, to verify that the instnunent is being directed towards the correct target and is bypassing organs such as blood vessels, which should not be penetrated by the instnunent.
,. - 2 Since a tumor may include"both cancerous tissue and non-cancerous tissue, it is important to be able to direct an instrument specificaIly to a cancerous portion of a tdnor, and to avoid misdiagnosis from the non-cancerous portion of a tumor.
In the case of a biopsy, the needle should be directed towards the portion of the tumor that is most likely to be cancerous. In the case of brachytherapy, the needle should be directed towards the cancerous portion of the tumor. Structural imaging modalities, such as CT and MRI, that have enough spatial accuracy and resolution to distinguish and resolve tumors, are nevertheless unable to differentiate cancerous tissue from non-cancerous tissue. Functional imaging modalities, including lo tomographic nuclear imaging modalities, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET),. can distinguish cancerous tissue from non-cancerous tissue, but lack the spatial ~:.
{ accuracy and resolution that is needed for the accurate positioning of instruments such as biopsy needles and brachytherapy needles.
Techniques for registering a functional image with a structural image to produce a combined image have been developed, and are disclosed, for example in the following publications: M. W. Vannier and D. E. Gayou, "Automated registration of multimodality images", Radiology, vol. 169 pp. 860-86I (1988);
J.
A. Correia, "Registration of nuclear medicine images, J. Nucl. Med, vol. 31 pp.
1227-1229 (1990); J-C Liehn, A. Loboguerrero, C. Perault and L. Demange, "superposition of computed tomogra.phy. . and single photon emission tomography l.. immunoscinigraphic images in the pelvis: validation in patients with colorectal or ovarian carcinoma recurrenee", Eur. J. Nucl. hled., vol. 19 pp. 186-194 (1992); F.
Thomas et al., "Description of a prototype emission transmission computed.
tomography imaging system",.J.' Nucir Med., vol. 33 pp: 1881-1887 (1992); D.
A.
Weber and M. Ivanovic, "Correlative image registration", Sem. Nuel. Med, vol, pp. 311-323 (1994); and Hasegawa et al., US Patent No. 5,376,795: In principle, a sequence of such combined images could be used to direct an instrument to the cancerous portion of a tumor. In practice, the multiple WO 00149958 PCr/iIA0100113 imaging sessions and registrations that this would require make this solution impractical and possibly dangerous.
Stereotaxis is a known technique for localizing a region inside the body of a patient from outside the body of the patient, and for directing an instrument such as a needle, or a narrow beam of therapeutic radiation, to the target region. The degree of accuracy obtained from stereotaxis is relatively high, so this technique has been considered useful mainly on the brain and the breast. In stereotactic surgery of the brain, a CT localization frame is attached rigidly to the head of a patient and a CT
image of the patient's brain is acquired with the CT localization frame in place. The io position of the CT localization frame in the CT image is used to position the patient with respect to a surgical instrament utilizing a source of radiation so that the beam or beams of radiation intersects the desired target. Note that the CT
localization firame is removed from the patient's head before the therapeutic irradiation commences.
Additionally, in order to access a correct location inside a patient's body with a diagnostic or therapeutic instruinent, it is desirable to have exact information on the physical dimensions of the instrument. Using existing tools, such informafion can be obtained by one of the following means: prompting the user to enter all relevant physical dimensions; keeping a software library of known instruments and prompting the user for a specific model type; or prompting the user to perform a series of actions with a caL'bration device. Needless to say, these are cumbersome and time-consuming procedures, and require caregiver assistance.
SUMMARY OF THE INYENTION
There is accordingly a need in the art to facilitate the technique of accessing a correct target region inside the patient's body with a diagnostic or therapeutic instivment, aimed at diagnosis and therapy purposes, by providing a novel method and system for guiding the instrument towards the target region, which is not necessarily located in the head or breast.
It is a major feature of the present invention to provide such a method that utilizes a combined image of at least a portion of the patient's body including a target region, which image is obtained by registering a high-resolution structural image and a relatively low-resolution functional image of this portion of the s patient's body.
It is a further feature of the present invention to provide such a system that utilizes a guiding device having an indicator associated with a diagnostic or therapeutic instrument for presenting data indicative of a position of the indicator relative to any other point in the chosen portion of the patient's body.
The main idea of the present invention consists of the utilization of a combined image, obtained by registering structural and functional images of at least a portion of the patient's body including a target region, for guiding an instrument (diagnostic or therapeutic) towards the target. The structural and fimctional images are obtained using, respectively, structural and functional modalities, namely -Is suitable known techniques, and the combined image is obtained by using any known suitable technique, for example, those disclosed in the above publications.
As used herein, the term "target" refers to a structarally discrete portion in the patient's body, such as an organ or a tuinor, that is suspected of containing diseas (e.g., cancerous tissue). This diseased tissue (target) is surrounded by healthy tissues (e.g., non-cancerous tissue).
As used herein, the term "instrument" refers to a diagnostic or treatment instrument that can access and, if desired, be inserted into the target from outside the patient for the purpose of either diagnosis or treatment of a disease.
Typical examples of such instiniments include biopsy needles and needles for brachytherapy 2s and chemotherapy.
According to one broad aspect of the present invention, there is provided a method for guiding an instrument towards a correct target inside the patient's body, the method comprising the steps of:
(i) providing an image of at least a portion of the patient's body including said target, wherein said image presents a combined image = WO 00/49958 PC1'/ll.UU1o0113 of registered structural and functional images of said at least portion of the patient's body;
(ii) providing. data indicative of a position of a location on the instruinent relative to any other point in said at least portion of the patient's body;and (iii) directing the instrument to said target.
To provide the combined image, the structtn-id and fnnctional images are obtained with, respectively, structural and fimctional modalities and registered.
While directing the instrument towards the target, at least one additional image of io the at least portion of the patient's body is preferably acquired with at least one of structural or functional modalities, for obtaining at least one additional combined image. Several additional images may be periodically or continuously acquired, and consequently, several additional combined images be obtained.
The structural and functional images used for obtaining the combined image may be, respectively, high-resolution and relatively low resolution. The resolution of 3-5mm pixel size is considered to be low, and that of less than Inun pixel size is considered to be high resolution. In this case, the at least one additional image may be a low-resolution functional image . or relatively higher resolution struchxral images (the so-called "medium-resolution" structural image). Alternatively, the structural and functionai images used for obtaining the combined image may each be of a low resolution, in which case the at least one additional image is acquired with high-resolution structural modality.
To provide the data indicative of the relative position of the instcument, a guiding device is used having an indicator associated with the instrament.
The guiding device may comprise a fi.-ame attachable to the patient's body and a stereotactic guide. The indicator is in the form of at least three markers on the frame. In this case, to provide the combined 'unage, the following steps are performed. The frame is rigidly secured to the patient, and then the high-resolution structural image is acquired using a high-resolution structural imaging modality, 3o such as CT or MRI. This high-resolution struchmal image includes at least the portion of the patient's body. The markers are used- by taking a series of structural images that covers all of them, since they are located in different planes. To acquire the functional image to.be registered with the so-obtained high-resolution structural image, a suitable radiopharmaceutical, that is taken up preferentralIy by cancerous S tissue (i.e., target), is injected into the patient, and the portion of the patient's body that was imaged with the stnictural modality is again imaged using a lower-resolution functional imaging modality that records radiation emitted by the radiopharmaceutical to acquire an image of the target. The structural image and the functional image are then registered to provide the combined image that shows the io relative location of the target relative to other elements in the combined image. In other words, the combined image shows which part of a twnor mass seen in the structural image contains cancer, and where the cancerous areas are located on the high-resolution structural image.
Prior to performing step (iii), the stereotactic guide is rigidly attached to the-1s fiame. Since the position of the target (e.g., cancerous tissue) relative to the frame is known, the position of the target relative to the stereotactic guide is also known.
The stereotactic guide then is used, under computer control, to guide the instrument, such as a biopsy needle or a brachytherapy needle, to the target, with reference to the pixels of the combined image that represent the markers and the 20 target. The trajectory of the instrument is programmed in advance so that the instiument does not penetrate organs, such as vascular structures, that should not be penetrated.
According to another broad aspect of the invention, there is provided a method for accessing a target in a patient's body with an instrument, the method 2s comprising the steps of:
(a) providing a guiding device having a frame to be secured to the patient and a stereotactic guide assembly, wherein the frame carries an indicator in the form of at least three markers;
(b) rigidly securing said frame to the patient;
WO DU/49958 PCTlIIAQ/00113 (c) imaging at least a portion of the patient's body including the target, using a structural imaging modality, to produce a siructural image of the at least portion of the patient's body and at least one of the markers, and acquiring a series of images to image all the markers and estimate their location in said structural image;
(d) imaging the at least portion of the patient's body using a functional imaging modality to produce a functional image of the at least portion of the patient's body; and (e) registering the functional image with the structural image to produce a combined image, (f) rigidly attaching said stereotactic guide assembly to said frame, and (g) directing the instrument to the target, using the stereotactic guide, with reference to said markers as imaged in the combined image.
According to another embodiment of the invention, the guiding device is a so-called tracking system composed of a guiding reference unit providing data indicative of space coordinates of the indicator that is in the form of a sensor attachable to the instrument at its handle portion, and a guiding controller.
The latter is interconnected between the indicator and the guiding reference, and is connected to a computer device displaying the combined image. Such a tracking system may be of any known type, e.g., magnetic, optical, inertial, sound-waves, GPS. The construction and operation of the tracking system are known per se, and do not form part of the present invention. Therefore, the operation of the tracking system does not need to be specifically described, except to note the following. The controller is capable of tracking the position of a sensor and obtaining the information indicative of six degrees of freedom (i.e., 3 position coordinates and 3 rotation angles). The controller is installed with suitable hardware and is operated by suitable software for performing a signal processing technique and generating data indicative of the sensor's position in the coordinate space defmed by the guiding reference. The computer device analyzes this data to generate a graphic WO 00/49958 PCT/1I.00/00113 -$-representation of instrument location on the structural or functional image, or directiom instructions for guiding the instrument towards'the target.
Magnetic tracking systems are based on a magnetic/electronic field, transmitter (guiding reference) and a relatively small receiver (indicator).
Such a system may, for example, be the miniBIItD 'model, commercially available from Ascension Technology Corporation. Optical tracking systems apply a visual perception technique that observes either light reflected items or small light emitters, for example POLARIS models, commercially available from Northern Digital Inc.
Additionally, the indicator may comprise an identification electronic chip attached to the handle-portion of the instrument. This is actually a chip with an mb dded application, such as a miniature electironic rnemory chip Prograrmued during the manufacture of the specifie instrument. The chip may be 'equipped with a transmitting utility generating and transmitting data indicative of the physical is dimensions of the instrument or its corresponding code in accordance with a coded library. Alternaxively or additionally, the chip may comprise a magnetic strip or a bar code to be read by a suitable reading head associated with the computer device.
According to another broad aspect of the present invention, there is provided a system for guiding an instrument towards a correct target inside the patient's 2o body, the system comprising:
1 - a computer device for displaying an image of at least a portion of the patient's body including said target, wherein said displayed image presents a combined image of registered structural and functional images _ of said at least portion of the patient's body;
25 - a guiding device having an indicator associated with said instrument for presenting data indicative of a position of a location on the instrument relative to any other point in said at least portion of the patient's body, said guiding device being connectable to said computer device and operable thereby for directing the instrument to said target.
*Trade-mark WO 00149958 PCT/IL00l00113 Freferably, the system also comprises an additional imaging modality capable of acquiring at least one of structuml and functional images of said at least portion of the patient's body. This additional imaging modality is operable for acquiring at_ least one image, used for obtaining at least one additional combined image (a so-called "updated combined image"). This at least one additional combined image is utilized, while directing the instrument towards the target.
Although the scope of the present invention includes the diagnosis and treatment of any diseased tissue, the present invention is described below in terms of the primary application thereof, the diagnosis and treatment of cancer.
to BRIEF DESCRIPTION OF THE DRAWIlNGS
In order to understand the invention and to see how it may be carried out in practice, a preferred embodiment will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:
Fig. 1 shows a patient wearing a frame;
Figs. 2A to 2C schematically illustrate axial sections of a Ga-67, a CT and a combined image of a chest of a patient;
Fig. 3 shows the patient of FIG. I with a stereotactic guide attached to the frame;
Fig. 4 illustrates the main constructional parts of a system according to 2o another embodiment of the invention;
Fig. 5 i1lUstrates another feature of the present invention suitable to be used in the embodiment of Figs. 1 and 3, or the embodiment of Fig. 4;
Figs. 6a and 6b illustxate two more examples of an indicator suitable to be used in the present invention; and Fig. 7 illustrates some more features of a method and system according the invention.
WO 00/49958 PCT/II.00/00113 DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
Referring to Figs. 1-3, there is illustrated one embodiment of the present invention utilizing a niethod of stereotactic diagnosis and treatment of diseased tissue. Fig. 1 shows a patient 10 wearing a rigid frame 12. By virtue of being snugly S fitted to the shoulders, waist and groin of patient 10, frame 12 is rigidly secured to patient 10. Frame 12 bears thereon three markers 14 (constituting an indicator) that include a material that shows up well in a high-resolution structural image of the patient 10 and fiame 12. For example, if CT is used for structural imaging, markers 14 are lead blocks. If MRI is used for structural imaging, markers 14 are hollow to plastic blocks filled with a solution of Gd-DTPA. Frame 12 also bears three attachment points 16 for a stereotactic guide. A high-resolution stntctural image of the portion of patient 10 that contains the target is acquired while patient 10 wears frame 12 as shown in Fig. 1.
Three is the. minimum number of markers 14 that is needed for accurately 15 recording the relative positions of frame 12 and the internal tissues of patient 10 in three dimensions in the structural image. Markers 14 are shown in Fig. 1 as three blocks only for illustrational clarity. Any suitable marker geometry or form may be used, for example, vertical and diagonal rods, as are used in the BRW ' CT
localization frame conunercially available from Radionics. Inc., of Burliuigton MA
20 and from Sofamor Danek, of Elektra, Sweden, for stereotactic 'treatment of the ( .t.. patient's brain. The positioning of markers 14 and attachment points 16 on frame 12 in Fig. 1 also is only illustrative, as an example of appropriate positions of markers 14 and attachment points 16 for treatment of the abdomen of patient 10.
Subsequent to or simultaneously with the acquisition of a high-resolution 25 structural (e.g., CT or MRI) image of the portion of patient 10 that includes the target (while the patient wears the frame), a lower resolution functional (e.g., nuclear medicine) image of the same portion of patient 10 is acquired for the purpose of imaging the target in the entire portion imaged by the structural modality. If the disease under treatment is cancer, then the preferred imaging *Trade-mark modality is nuclear imaging, and the patient is injected before imaging with a radiopharmaceutical that is preferentially taken up by cancerous tissue.
Examples of such radiopharmaceuticals include Ga-67, Tc-99m MEBI, T1-201, F-18 fluorodeoxyglucose and In-i l l octreotide. The most preferred nuclear imaging modalities are tomographic modalities such as SPECT and PET. The functional and structural images then are registered, for example as described. in the paper by Weber and Ivanovic cited above, to produce a combined image.
Fig. 2A is a schematic illustration of an axial section of a Ga-67 image If...
of a chest of a cancer patient, showing a tumor T containing a lymphoma that to constitutes the target TG to be accessed by an instrument (not shown). Fig.
2B is a schematic illustration of an axial section of a CT image Iu,n of the same patient's chest. A portion P of the patient's body including the tumor T is imaged. The target TG is not seen in the structural image since there is typically no visual contrast in such image between the lymphoma and the rest of the tumor. What can Is be seen in such a structural image are organs and tissues, generally at OR, surrounding the tumor T (and consequently the target to be detected), and typically one of the markers 14 on the frame. Although three markers are presented in the drawings as seen in the structural image, two of them are shown in dotted lines, since the markers are located in different planes, and only one of them will be seen 2o in such a sectional view. Fig. 2C is an axial section of a combined image Ic,m, showing the functional image It~.. of Fig. 2A registered on the structural image I,a of Fig. 2B. Any known suitable technique can be used for registering images of Figs. 2A and 2B to obtain the combined image of Fig. 2C, for example the techniques descnbed in the above-indicated publications. Biopsy and therapy 25 directed towards the tumor should be aimed specifically at the lymphoma.
Fig. 3 shows patient 10 with a stereotactic guide 18 finnly and rigidly attached to frame 12 at attachment points 16, and with a diagnostic or therapeutic insttvment 20, such as a biopsy needle or a brachytherapy needle, mounted in stereotactic guide 18 in its ready-for-insertion position to be inserted into the 3o abdomeii of patient 10 under the control of a computer device 24.
WO 00/49958 PCT/IUl0/00113 Computer 24 is equipped with suitable hardware and operated by suitable software for sending control signals, including the relevant Cartesian coordinates, to stereotactic guide 18 via suitable signal communication means, for example electrical connection such as a cable 22. It should be understood, although not specifically shown, that wireless connection could be used. Computer 24 also includes a suitable display mechanism, such as a video terminal, for displaying the combined image.
A physician programs the trajectory of instrument 22 in computer 24 in advance, with reference to the position of the target TG and the other intemal organs OR ofpatient 10, and with reference to markers 14, as seen in the combined image I.. Computer 24 is installed with suitable software that transfonns data indicative of the coordinate system of the combined image, as defined by markers 14, into the coordinate system of stereotactic guide 18. This software is used to transfonn the coordinates of the trajectory, which is defined by the physician in the coordinate system of the combined image, into the coordinate system of stereotactic guide 18, to enable stereotactic guide 18 to steer instrument 20 along the desired tqajeetoid. The physician designs the trajectory to avoid vascular structures and other organs that should not be penetrated by instrament 20.
To assist the physician in recognizing and avoiding vascular structures such -~
2o as blood vessels, another functional image of the portion of patient 10 that includes the target is acquired, for the purpose of imaging the blood vessels. The preferred imaging modality for imaging vascular structures is Tc-99m labeled red blood cells SPECT. For this purpose, patient 10 is frst injected with Tc-99m, to label the red blood cells of patient 10. The SPECT image of the vascular structures is registered with the structural image initially obtained and utilized in the initial combined image shown in Fig. 2C, and a resulting second combined image is displayed by computer 24 and is used by the physician in planning the trajectory of instrument 20 to avoid penetration of the imaged vascular structures.
Similarly, to assist the physician in recognizing and avoiding organs such as the kidneys, another functional image of the portion of patient 10 that includes the II
target is acquired. In the specific case of the kidneys, this second fanctionai image is a SPECT image obtained using Tc-99 DMSA. The SPECT image of the organ or organs is registered with the structural image, and the resulting second combined image is displayed by computer 24 and is used by the physician in planning the trajectory of instnunent 20 to avoid penetration of the imaged organs. To prevent errors in planning the trajectory of instrument 20, computer 24 is programmed to avoid penetration of blood vessels and organs with a high blood pool, and other organs that should not be penetrated, such as the gut, the kidneys, the pancreas and the heart.
10It should be understood that more than one additional combined image can be obtained, the number of these additional images depending on a specific application, e.g., a target to be accessed. A physician himself decides how many updates of the initial combined 'unages are needed for successfully guide the instrument towards the target.
In the above-described example of the present invention, the biopsy needle guidance utilizes the stereotactic guide assembly, with reference to the diseased portion of the patient's body and to the markers as imaged on the first combined image. In other words, in the above-described example, a guiding device is constituted by the frame with markers and by the stereotactic guide assembly.
2o However, other guidance and motion tracking systems are suitable as well.
Such systems are, but not lirnited to magnetic and optical systems.
Reference is made to Fig. 4, ilhistrating the main components of a system, generally designated 100, according to another emboditnent of the invention.
System 100 is composed of an indicator 126 appropriately attached to a handle 2s portion 122 of an instnunent 120, a guiding reference unit 128 and a guiding controller 130 connected to the computer 24.
As indicated above, such a system may be of magnetic or optical kind,for example, commercially, available from Ascension Technology Corporation and Northern Digital Inc., respectively. Generally speaking, the guiding reference unit 30 128 and the indicator 126 operate together to generate data indicative of the indicator position in a 6D coordinate space (3 position coordinates and 3 rotation angles) and transmit this data to the guiding controller 130. The latter h ansmits corresponding data to the computer device 24, which registers this data with the combined image to generate a graphic representation of the instrument's location s. on the structural or functional image or direction instructions for guiding the instrument 120 towards the target, as described above.
Turning now to Fig. 5, there. is illustrated an inshwnent 220 having a handle portian 222 formed with an identification chip 226. As indicated above, a major factor in the accuracy of the system of the kind specified is exact information on lo the physical dimensions of a diagnostic or therapeutic instrument associated with a guiding device. To this end, the diagnostic or therapeutic instrument 220 according to the invention is equipped with the chip 226 with an embedded application enabling the identification of the physical dimensions of the specific instmment.
The chip provides data indicative of the inshvment's physical parameters, which 15 may be d'umensions themselves, or coded data that can be identified by the software installed in the computer 24 (i.e., library storing information corresponding to various Serial Numbers of diagnostic 'and therapeutic instnunents manufactured by various manufacturers). The computer 24 itself may have a special utility for communicating with the embedded application of the chip.
20 According to the present invention, diagnosis and/or treatment are performed with respect to an image of the target region in the patient's body that combines a high-resolution structural image, such as a CT or MItI image, with a lower resolution fimctional image, such as a nuclear image. The combined image may be used to assist the caregiver in locating the instrument with respect to the 25 target. Pieces of materials that are clearly shown in one of the modalities may be used to gain information in the combined image. Such materials are, but not limited to, radioactive emitters that are clearly seen by means of the nuclear medicine image, and lead capsules that are highly visible in a CT image. Such pieces can be attached to known locations on the therapeutic instnunent, thereby serving as 30 indicators. These indicators are useful in the procedure navigation process, where WO UU/49958 PCTn1.00/00113 the physician inserts the instrtunent toward the target. At the end of the procedure there is a verification phase, where the physician validates the location of the instrurnent with respect to the target. During the verification phase both the tissue and the highlight indicator are clearly seen in the combined image. This increases S the degree of confidence that the prqcedure instmmnent was correctly applied.
Fig. 6A shows the main principles of the above concept. Here, such an indicator 326 (e.g., radioactive emitters) is attached to a location on an instrvment 320 close to its handle portion 322.
Fig. 6B illustrates an example where treatment of the target is needed. To io this end, a therapeutic instrument 420 is at its distal end formed with a suitable materiat 422 that can be clearly seen in an image of one of the modalities to gain information in the combined image. Thus, the therapeutic instrument 420 is initially inserted by its distal end into a vessel containing materia1422, and is then directed towards the target TG. Such materials are, but not Iimited to, radioactive materials ts that are clearly seen by means of the nuclear medicine image, and iodine that is highly visi'ble in a CT image. The highlight material may also be mixed with the therapeutic chemical in advance. The highlight materials are injected together with therapeutic chemical substances and are used to track the absorption of the substances with respect to the tumor while minimizing damage to the seurounding 2o healthy tissue.
As indicated above, diagnosis is performed with respect to an image of the target region of the patient that combines a high-resolution structural image, such as a CT or MRI image, with a lower resolution functional image, such as a nuclear image. For various reasons, a physician may prefer to perform the clinical 25 procedure under single modality equipment that may be different from the equipment originally used to make the combined image. In this case, the combined image is made of a relatively high-resolution structural image, lower resolution functionai imaga, and another image that may be eitheD stwctin-al on functional of a different resolution. For example, a low-resolution PET image may be combined 30 with a medium-resolution CT image, which images are collected during a preliminarydiagnostic procedure. The actual procedure is carried out under a high-resolution CT or MRI imaging, that was designed for such procedures.
The above concept is schematically iIlustrated -in Fig. 7, showing a system 50 utilizing low-resohrtion CT imaging modality (as compared to that used during the instnnnent insertion procedure) and low-resohrtion PET imaging modaiity, generally at 502, that obtain a combined image of a portion of the patient's body including a target and transniit- data to a computer device 24 and to a high-resolution CT modality 504 through a computer network. A guiding device 506 associated with a diagnostic or therapeutic instrwnent 520 and coupled to the i o computer 24, is used for guiding the instiument towards the target with simultaneous image acquisition with the high-resolution CT imaging modality 504:
Those skilled in the art will readily appreciate that various modifications and changes can be applied to the preferred embodiment of the invention as hereinbefore described without departing from its scope defined in and by the appended claims.
Claims (24)
1. A system for guiding an instrument, with respect to at least one functionally-active target, inside a patient's body, said system comprising:
a rigid frame, which includes:
a rigid structure;
fittings, attached to the rigid structure, for snugly securing said frame to the patient's body; and at least three fiducial marks, arranged at different locations, on said frame;
a first structural imaging modality, adapted for imaging different densities within the patient's body, for obtaining a first structural image, said first structural imaging modality being further adapted to detect said at least three fiducial marks, for defining at least a two-dimensional coordinate system;
a first functional imaging modality, adapted for imaging radioactively tagged pharmaceuticals, administered to the patient and distributed in the patient's body due to physiological activities, for obtaining a first functional image, which includes said at least one functionally-active target, wherein said first functional imaging modality is spatially registered to said coordinate system;
a computer device, for receiving input from said first structural and functional imaging modalities and for simultaneously displaying both, as a superposition of said functional and structural images; and a stereotactic guide, selectively attached to said rigid frame, so as to be spatially registered to said coordinate system, said stereotactic guide having an instrument mounted thereon, for guiding said instrument with respect to said at least one functionally-active target, detected by the functional image, based on said superposition of said functional and structural images, under the control of said computer device.
a rigid frame, which includes:
a rigid structure;
fittings, attached to the rigid structure, for snugly securing said frame to the patient's body; and at least three fiducial marks, arranged at different locations, on said frame;
a first structural imaging modality, adapted for imaging different densities within the patient's body, for obtaining a first structural image, said first structural imaging modality being further adapted to detect said at least three fiducial marks, for defining at least a two-dimensional coordinate system;
a first functional imaging modality, adapted for imaging radioactively tagged pharmaceuticals, administered to the patient and distributed in the patient's body due to physiological activities, for obtaining a first functional image, which includes said at least one functionally-active target, wherein said first functional imaging modality is spatially registered to said coordinate system;
a computer device, for receiving input from said first structural and functional imaging modalities and for simultaneously displaying both, as a superposition of said functional and structural images; and a stereotactic guide, selectively attached to said rigid frame, so as to be spatially registered to said coordinate system, said stereotactic guide having an instrument mounted thereon, for guiding said instrument with respect to said at least one functionally-active target, detected by the functional image, based on said superposition of said functional and structural images, under the control of said computer device.
2. The system of claim 1, wherein said at least one functionally-active target is a suspected malignancy and said system is adapted for guiding said instrument to said at least one functionally-active target.
3. The system of claim 1, adapted for guiding said instrument to a first functionally-active target, which is a suspected malignancy, through a trajectory that avoids at least one other functionally-active target, selected from the group consisting of a blood vessel, a kidney, the gastrointestinal tract, the pancreas, the heart, a breast, the prostate, a thyroid gland, a lung, the brain, a lymph node, a bone, an ovary, the colon, the rectum.
4. The system of any one of claims 1-3, wherein said first structural imaging modality is MRI.
5. The system of claim 4, wherein said fiducial marks are formed as hollow plastic containers filled with a solution of Gd-DTPA.
6. The system of any one of claims 1-3, wherein said first structural imaging modality is CT.
7. The system of claim 6, wherein said fiducial marks are formed of lead.
8. The system according to any one of claims 1-7, wherein said first functional imaging modality is nuclear imaging, selected from the group consisting of two-dimensional gamma camera imaging, three-dimensional PET imaging and three-dimensional SPECT
imaging.
imaging.
9. The system according to any one of claims 1-8, wherein said system comprises at least one additional functional imaging modality, spatially registered to said coordinate system.
10. The system of claim 9, wherein said computer device is adapted for simultaneously displaying an image of said at least one additional functional imaging modality, superimposed on said first structural imaging modality.
11. The system of claim 9 or 10, wherein said at least one additional functional imaging modality is adapted for imaging at least one body organ which should not be penetrated.
12. The system of any one of claims 9-11, wherein said at least one additional functional imaging modality is adapted for imaging at least one organ selected from the group consisting of a blood vessel, the kidney, the gastrointestinal tract, the pancreas, the heart, a breast, the prostate, a thyroid gland, a lung, the brain, a lymph node, a bone, an ovary, the colon, the rectum.
13. The system according to any one of claims 1-12, said system comprising at least one additional structural imaging modality, of a lower resolution than said first structural imaging modality, spatially registered to said coordinate system.
14. The system according to any one of claims 1-13, wherein said at least thee fiducial marks are arranged on at least two different planes, for providing a three-dimensional coordinate system.
15. The system according to any one of claims 1-14, wherein said stereotactic guide includes an optical guiding system.
16. The system according to any one of claims 1-15, wherein said stereotactic guide includes a magnetic guiding system.
17. The system according to any one of claims 1-16, wherein said instrument includes an indicator, in communication with said computer device, for generating and transmitting data, indicative of said instrument's position, in a six-dimensional space.
18. The system according to any one of claims 1-17, wherein said instrument includes an identification chip, in communication with said computer device, for providing exact information on the physical dimensions of said instrument.
19. The system according to any one of claims 1-18, wherein said instrument includes a highlight mark.
20. The system of claim 19, wherein said highlight mark includes a lead capsule, which is visible on a CT image.
21. The system of claim 19 or 20, wherein said highlight mark includes iodine, which is visible on a CT image.
22. The system of claim 21, wherein said iodine is mixed with a therapeutic solution.
23. The system of any one of claims 19 - 22, wherein said highlight mark includes a radioactive material, which is visible on a nuclear image.
24. The system of claim 23, wherein said radioactive material is mixed with a therapeutic solution.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/253,779 | 1999-02-22 | ||
| US09/253,779 US6173201B1 (en) | 1999-02-22 | 1999-02-22 | Stereotactic diagnosis and treatment with reference to a combined image |
| PCT/IL2000/000113 WO2000049958A1 (en) | 1999-02-22 | 2000-02-22 | A method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2362981A1 CA2362981A1 (en) | 2000-08-31 |
| CA2362981C true CA2362981C (en) | 2009-01-06 |
Family
ID=22961669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002362981A Expired - Lifetime CA2362981C (en) | 1999-02-22 | 2000-02-22 | A method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6173201B1 (en) |
| EP (1) | EP1162921A1 (en) |
| JP (1) | JP2002541885A (en) |
| AU (1) | AU766301B2 (en) |
| CA (1) | CA2362981C (en) |
| IL (1) | IL144786A0 (en) |
| WO (1) | WO2000049958A1 (en) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7853311B1 (en) * | 1999-04-23 | 2010-12-14 | 3M Innovative Properties Company | Surgical targeting system |
| CA2374040C (en) * | 1999-07-02 | 2010-10-19 | Hypermed Imaging, Inc. | Integrated imaging apparatus |
| SE515683C2 (en) * | 1999-12-20 | 2001-09-24 | Jan A G Willen | Device for compression of the throat pillar for medical image acquisition purposes |
| US8036731B2 (en) * | 2001-01-22 | 2011-10-11 | Spectrum Dynamics Llc | Ingestible pill for diagnosing a gastrointestinal tract |
| US8565860B2 (en) * | 2000-08-21 | 2013-10-22 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system |
| US8909325B2 (en) * | 2000-08-21 | 2014-12-09 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| US8489176B1 (en) * | 2000-08-21 | 2013-07-16 | Spectrum Dynamics Llc | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| US7826889B2 (en) * | 2000-08-21 | 2010-11-02 | Spectrum Dynamics Llc | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
| CN1310617C (en) * | 2001-01-22 | 2007-04-18 | V-目标技术有限公司 | Ingestible pill |
| US20030055436A1 (en) * | 2001-09-14 | 2003-03-20 | Wolfgang Daum | Navigation of a medical instrument |
| EP1502237A2 (en) | 2002-04-03 | 2005-02-02 | Segami S.A.R.L. | Image registration process |
| US20050277823A1 (en) * | 2002-06-10 | 2005-12-15 | Robert Sutherland | Angiogram display overlay technique for tracking vascular intervention sites |
| US7106892B2 (en) * | 2002-09-19 | 2006-09-12 | Koninklijke Philips Electronics, N.V. | Display of image data information |
| US20040116807A1 (en) * | 2002-10-17 | 2004-06-17 | Roni Amrami | Blood vessels wall imaging catheter |
| US20040204646A1 (en) * | 2002-11-04 | 2004-10-14 | V-Target Technologies Ltd. | Intracorporeal-imaging head |
| AU2003276658A1 (en) | 2002-11-04 | 2004-06-07 | V-Target Technologies Ltd. | Apparatus and methods for imaging and attenuation correction |
| US8150495B2 (en) | 2003-08-11 | 2012-04-03 | Veran Medical Technologies, Inc. | Bodily sealants and methods and apparatus for image-guided delivery of same |
| US7398116B2 (en) * | 2003-08-11 | 2008-07-08 | Veran Medical Technologies, Inc. | Methods, apparatuses, and systems useful in conducting image guided interventions |
| US9392961B2 (en) | 2003-12-17 | 2016-07-19 | Check-Cap Ltd. | Intra-lumen polyp detection |
| CN101791220B (en) * | 2003-12-17 | 2013-06-12 | 切克卡普有限公司 | Intra-lumen polyp detection |
| US9040016B2 (en) * | 2004-01-13 | 2015-05-26 | Biosensors International Group, Ltd. | Diagnostic kit and methods for radioimaging myocardial perfusion |
| WO2005067383A2 (en) * | 2004-01-13 | 2005-07-28 | Spectrum Dynamics Llc | Multi-dimensional image reconstruction |
| US8571881B2 (en) * | 2004-11-09 | 2013-10-29 | Spectrum Dynamics, Llc | Radiopharmaceutical dispensing, administration, and imaging |
| US8586932B2 (en) | 2004-11-09 | 2013-11-19 | Spectrum Dynamics Llc | System and method for radioactive emission measurement |
| US9470801B2 (en) * | 2004-01-13 | 2016-10-18 | Spectrum Dynamics Llc | Gating with anatomically varying durations |
| US7968851B2 (en) * | 2004-01-13 | 2011-06-28 | Spectrum Dynamics Llc | Dynamic spect camera |
| US8280124B2 (en) | 2004-06-01 | 2012-10-02 | Spectrum Dynamics Llc | Methods of view selection for radioactive emission measurements |
| EP1778957A4 (en) * | 2004-06-01 | 2015-12-23 | Biosensors Int Group Ltd | Radioactive-emission-measurement optimization to specific body structures |
| US8615405B2 (en) | 2004-11-09 | 2013-12-24 | Biosensors International Group, Ltd. | Imaging system customization using data from radiopharmaceutical-associated data carrier |
| US9316743B2 (en) | 2004-11-09 | 2016-04-19 | Biosensors International Group, Ltd. | System and method for radioactive emission measurement |
| US9943274B2 (en) | 2004-11-09 | 2018-04-17 | Spectrum Dynamics Medical Limited | Radioimaging using low dose isotope |
| US8000773B2 (en) * | 2004-11-09 | 2011-08-16 | Spectrum Dynamics Llc | Radioimaging |
| EP1827505A4 (en) * | 2004-11-09 | 2017-07-12 | Biosensors International Group, Ltd. | Radioimaging |
| US20080260637A1 (en) * | 2004-11-17 | 2008-10-23 | Dalia Dickman | Methods of Detecting Prostate Cancer |
| WO2008059489A2 (en) * | 2006-11-13 | 2008-05-22 | Spectrum Dynamics Llc | Radioimaging applications of and novel formulations of teboroxime |
| US7872235B2 (en) | 2005-01-13 | 2011-01-18 | Spectrum Dynamics Llc | Multi-dimensional image reconstruction and analysis for expert-system diagnosis |
| US7831293B2 (en) * | 2005-05-10 | 2010-11-09 | Advanced Clinical Solutions, Inc. | Method of defining a biological target for treatment |
| US7628957B1 (en) * | 2005-06-27 | 2009-12-08 | Moseley Patrick T | Carbon dioxide sensor |
| US8644910B2 (en) * | 2005-07-19 | 2014-02-04 | Biosensors International Group, Ltd. | Imaging protocols |
| EP1908011B1 (en) * | 2005-07-19 | 2013-09-04 | Spectrum Dynamics LLC | Reconstruction stabilizer and active vision |
| US8837793B2 (en) | 2005-07-19 | 2014-09-16 | Biosensors International Group, Ltd. | Reconstruction stabilizer and active vision |
| US20070066881A1 (en) * | 2005-09-13 | 2007-03-22 | Edwards Jerome R | Apparatus and method for image guided accuracy verification |
| EP1924198B1 (en) | 2005-09-13 | 2019-04-03 | Veran Medical Technologies, Inc. | Apparatus for image guided accuracy verification |
| US7831075B2 (en) * | 2005-10-20 | 2010-11-09 | Case Western Reserve University | Imaging system |
| US7705316B2 (en) * | 2005-11-09 | 2010-04-27 | Spectrum Dynamics Llc | Dynamic SPECT camera |
| EP1966984A2 (en) | 2005-12-28 | 2008-09-10 | Starhome GmbH | Optimal voicemail deposit for roaming cellular telephony |
| US8894974B2 (en) * | 2006-05-11 | 2014-11-25 | Spectrum Dynamics Llc | Radiopharmaceuticals for diagnosis and therapy |
| US20080086059A1 (en) * | 2006-10-04 | 2008-04-10 | Cynthia Keppel | Method and apparatus for lesion localization using a dual modality x-ray/gamma biopsy system |
| WO2008075362A2 (en) * | 2006-12-20 | 2008-06-26 | Spectrum Dynamics Llc | A method, a system, and an apparatus for using and processing multidimensional data |
| CA2677581C (en) | 2007-02-06 | 2018-11-13 | Yoav Kimchy | Intra-lumen polyp detection |
| US20080221443A1 (en) * | 2007-03-07 | 2008-09-11 | Ritchie Paul G | Integrated Imaging and Biopsy System with Ancillary Device Authentication |
| US8521253B2 (en) * | 2007-10-29 | 2013-08-27 | Spectrum Dynamics Llc | Prostate imaging |
| US7795591B2 (en) * | 2008-07-16 | 2010-09-14 | Dilon Technologies, Inc. | Dual-capillary obturator for real-time verification in gamma guided stereotactic localization |
| US8338788B2 (en) | 2009-07-29 | 2012-12-25 | Spectrum Dynamics Llc | Method and system of optimized volumetric imaging |
| WO2012169990A2 (en) | 2010-05-04 | 2012-12-13 | Pathfinder Therapeutics, Inc. | System and method for abdominal surface matching using pseudo-features |
| US8696549B2 (en) | 2010-08-20 | 2014-04-15 | Veran Medical Technologies, Inc. | Apparatus and method for four dimensional soft tissue navigation in endoscopic applications |
| US10249036B2 (en) | 2012-02-22 | 2019-04-02 | Veran Medical Technologies, Inc. | Surgical catheter having side exiting medical instrument and related systems and methods for four dimensional soft tissue navigation |
| EP3647822A3 (en) | 2012-05-08 | 2020-08-12 | Spectrum Dynamics Medical Limited | Nuclear medicine tomography systems, detectors and methods |
| US20150305612A1 (en) | 2014-04-23 | 2015-10-29 | Mark Hunter | Apparatuses and methods for registering a real-time image feed from an imaging device to a steerable catheter |
| US20150305650A1 (en) | 2014-04-23 | 2015-10-29 | Mark Hunter | Apparatuses and methods for endobronchial navigation to and confirmation of the location of a target tissue and percutaneous interception of the target tissue |
| US10806523B2 (en) | 2015-12-28 | 2020-10-20 | Xact Robotics Ltd. | Adjustable registration frame |
| CN113075599B (en) * | 2020-01-03 | 2023-05-16 | 上海联影医疗科技股份有限公司 | Magnetic resonance signal acquisition method, magnetic resonance system and medium |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376795A (en) | 1990-07-09 | 1994-12-27 | Regents Of The University Of California | Emission-transmission imaging system using single energy and dual energy transmission and radionuclide emission data |
| US5517990A (en) * | 1992-11-30 | 1996-05-21 | The Cleveland Clinic Foundation | Stereotaxy wand and tool guide |
| US5682890A (en) * | 1995-01-26 | 1997-11-04 | Picker International, Inc. | Magnetic resonance stereotactic surgery with exoskeleton tissue stabilization |
| DE69840161D1 (en) * | 1997-02-14 | 2008-12-11 | Biosense Webster Inc | THROUGH X-RAY SURGICAL SURGICAL LOCALIZATION SYSTEM |
| US6021342A (en) * | 1997-06-30 | 2000-02-01 | Neorad A/S | Apparatus for assisting percutaneous computed tomography-guided surgical activity |
-
1999
- 1999-02-22 US US09/253,779 patent/US6173201B1/en not_active Expired - Lifetime
-
2000
- 2000-02-22 WO PCT/IL2000/000113 patent/WO2000049958A1/en not_active Application Discontinuation
- 2000-02-22 EP EP00906576A patent/EP1162921A1/en not_active Withdrawn
- 2000-02-22 CA CA002362981A patent/CA2362981C/en not_active Expired - Lifetime
- 2000-02-22 IL IL14478600A patent/IL144786A0/en not_active IP Right Cessation
- 2000-02-22 AU AU28232/00A patent/AU766301B2/en not_active Expired
- 2000-02-22 JP JP2000600573A patent/JP2002541885A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL144786A0 (en) | 2002-12-01 |
| JP2002541885A (en) | 2002-12-10 |
| US6173201B1 (en) | 2001-01-09 |
| CA2362981A1 (en) | 2000-08-31 |
| AU2823200A (en) | 2000-09-14 |
| AU766301B2 (en) | 2003-10-16 |
| WO2000049958A1 (en) | 2000-08-31 |
| EP1162921A1 (en) | 2001-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2362981C (en) | A method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body | |
| US6567687B2 (en) | Method and system for guiding a diagnostic or therapeutic instrument towards a target region inside the patient's body | |
| US7826889B2 (en) | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures | |
| EP1795142B1 (en) | Medical tracking system using a gamma camera | |
| US6546279B1 (en) | Computer controlled guidance of a biopsy needle | |
| EP1715788B1 (en) | Method and apparatus for registration, verification, and referencing of internal organs | |
| US6678546B2 (en) | Medical instrument guidance using stereo radiolocation | |
| US9202387B2 (en) | Methods for planning and performing percutaneous needle procedures | |
| CA2575759C (en) | Tumor treatment identification system | |
| US20070100225A1 (en) | Medical imaging modality | |
| EP3021940B1 (en) | Portal imaging for brachytherapy | |
| CN101243332A (en) | Tissue interventions using nuclear-emission image guidance | |
| WO2004019799A2 (en) | Methods and systems for localizing of a medical imaging probe and of a biopsy needle | |
| Sánchez et al. | Navigational guidance and ablation planning tools for interventional radiology | |
| US8489176B1 (en) | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures | |
| Vijayalakshmi | Image-guided surgery through internet of things | |
| US20130158388A1 (en) | Needle guidance for molecular imaging | |
| RU2130759C1 (en) | Method for directing stereotactic instrument to a target point | |
| Jain et al. | Current Status of Radiological Multimodality Imaging | |
| Wong | Imaging modalities | |
| Huang et al. | An automated image-guided robot arm system for small animal tissue biopsy studies | |
| Novotny, Jr et al. | Comparison of different techniques for stereotactic positron emission tomography Imaging |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20200224 |